TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
Preller V, Gerber A, Wrenger S, Togni M, Marguet D, Tadje J, Lendeckel U, Röcken C, Faust J, Neubert K, Schraven B, Martin R, Ansorge S, Brocke S, Reinhold D.
Preller V, et al. Among authors: schraven b.
J Immunol. 2007 Apr 1;178(7):4632-40. doi: 10.4049/jimmunol.178.7.4632.
J Immunol. 2007.
PMID: 17372022